A new trading day began on Monday, with Abbvie Inc (NYSE: ABBV) stock price down -0.35% from the previous day of trading, before settling in for the closing price of $194.29. ABBV’s price has ranged from $135.85 to $199.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.76% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -2.19%. With a float of $1.76 billion, this company’s outstanding shares have now reached $1.77 billion.
In an organization with 50000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 72.49%, operating margin of 27.0%, and the pretax margin is 12.85%.
Abbvie Inc (ABBV) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Abbvie Inc is 0.09%, while institutional ownership is 73.03%. The most recent insider transaction that took place on Aug 08 ’24, was worth 9,297,210. Before that another transaction happened on Aug 05 ’24, when Company’s EXECUTIVE CHAIRMAN OF BOARD sold 66,500 for $186.52, making the entire transaction worth $12,403,580. This insider now owns 446,599 shares in total.
Abbvie Inc (ABBV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -2.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.10% during the next five years compared to -5.77% drop over the previous five years of trading.
Abbvie Inc (NYSE: ABBV) Trading Performance Indicators
Here are Abbvie Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.22. Likewise, its price to free cash flow for the trailing twelve months is 19.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.99, a number that is poised to hit 2.95 in the next quarter and is forecasted to reach 12.10 in one year’s time.
Technical Analysis of Abbvie Inc (ABBV)
Let’s dig in a bit further. During the last 5-days, its volume was 4.02 million. That was inferior than the volume of 5.33 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.68%. Additionally, its Average True Range was 3.15.
During the past 100 days, Abbvie Inc’s (ABBV) raw stochastic average was set at 86.33%, which indicates a significant increase from 42.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 11.14% in the past 14 days, which was lower than the 19.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $193.30, while its 200-day Moving Average is $174.74. However, in the short run, Abbvie Inc’s stock first resistance to watch stands at $194.86. Second resistance stands at $196.10. The third major resistance level sits at $197.11. If the price goes on to break the first support level at $192.60, it is likely to go to the next support level at $191.59. The third support level lies at $190.34 if the price breaches the second support level.
Abbvie Inc (NYSE: ABBV) Key Stats
With a market capitalization of 341.98 billion, the company has a total of 1,765,868K Shares Outstanding. Currently, annual sales are 54,318 M while annual income is 4,863 M. The company’s previous quarter sales were 14,462 M while its latest quarter income was 1,370 M.
